mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.02 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.15 |
0.02 |